A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...

Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with ...

Chemists at Université de Montréal have developed "signaling cascades" made with DNA molecules to report and quantify the ...

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

A study published in Science reveals a cellular mechanism involved in the inheritance of genetic mutations. The study also ...

Advances in genome editing are transforming the treatment for rare genetic diseases, as seen in the case of seven-month-old ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Scientists developed a fast DNA damage test for radiation that could guide cancer care and help responders deliver personalized treatment during radiological emergencies. (Nanowerk News) Scientists at ...

New research found that gene therapy for children with "bubble boy disease," or SCID, was successful in 95% of trial ...

Inspired by living cells, researchers have designed DNA molecules that allow drug concentrations in blood to be measured ...